CANINE EHRLICHIOSIS: INTEGRATIVE REVIEW OF CASE STUDIES ON TREATMENTS BETWEEN 2020 AND 2024
DOI:
https://doi.org/10.56238/Keywords:
Canine Ehrlichiosis, Ehrlichia canis, Tick Rhipicephalus sanguineus, Doxycycline, Treatment, Veterinary MedicineAbstract
Canine ehrlichiosis, caused by the bacterium Ehrlichia canis and transmitted by the tick Rhipicephalus sanguineus, is a severe systemic disease. This study conducted an integrative review of clinical cases published between 2020 and 2024, focusing on the therapeutic protocols used and the patients' responses. Doxycycline was the most frequently used antibiotic, with variations in dosage and the need for additional clinical support. Treatment effectiveness is associated with early diagnosis, appropriate clinical management, and the continuous use of preventive measures. Despite recent advances, challenges remain in standardizing care and raising awareness among pet owners, highlighting the need for educational initiatives and public veterinary policies.
